EXPERIENCE OF ENDOVIRAZA APPLICATION IN THE TREATMENT OF PANNEYKOPENIYA AND CORONOVIRUS ENTREIT IN CATS

Abstract

Data on the use as an antiviral drug of endovirase in the treatment of cats suffering from panleukopenia and coronavirus enteritis are given. The studies are conducted in a comparative aspect with reaferon-EC. It is shown that the use of endovirase significantly shortens the duration of treatment for panleukopenia and, in particular, coronavirus enteritis. The effectiveness of treatment is confirmed by the results of PCR diagnostics and blood tests.